PATRICK WALSH

Corporate Board Profile

Tech Score: 0/100

BJs RESTAURANTS INC

Filing Date	Source Excerpt
2014-04-30	PATRICK WALSH has served as the Managing Member and Chief Executive Officer of PW Partners, LLC and PW Partners Atlas Funds, LLC ... Subject to their election at the Annual Meeting, it is expected that the Company will appoint Mr. Walsh and Mr. McEachen to serve on the Compensation Committee (which shall be increased from four members to five members), Mr. McEachen to serve on the Audit Committee, and Mr. Elbogen to serve on the Governance and Nominating Committee.

Filing Date

Source Excerpt

2014-04-30

PATRICK WALSH has served as the Managing Member and Chief Executive Officer of PW Partners, LLC and PW Partners Atlas Funds, LLC ... Subject to their election at the Annual Meeting, it is expected that the Company will appoint Mr. Walsh and Mr. McEachen to serve on the Compensation Committee (which shall be increased from four members to five members), Mr. McEachen to serve on the Audit Committee, and Mr. Elbogen to serve on the Governance and Nominating Committee.

LIFECORE BIOMEDICAL, INC. \DE\

Filing Date	Source Excerpt
2020-08-31	Patrick D. Walsh is a nominee to the Board of Directors. He is founder of Diligence Team, LLC, a consulting practice serving clients in the healthcare industry. Mr. Walsh has served as Chairman of the Board of Directors of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), a publicly traded specialty pharmaceutical company, since June 2018, and is a former member of its Audit and Compensation Committees. He has also served as a Director for Avid Bioservices, Inc. (NASDAQ:CDMO) since October 2017, and is Chairman of its Compensation Committee and a member of its Nominating Committee. Mr. Walsh currently serves as an Operating Partner at Ampersand Capital, a private-equity healthcare investment firm, and has served on the boards of directors of pharmaceutical companies as chairman, non-executive chairman and company director, as well as an executive advisor to private equity and venture capital firms. He also currently serves on the Board of Directors of Industria Chimica Emiliana, S.p.A. ("I.C.E."), a privately - held specialty API supplier to the pharmaceutical industry based in Milan, Italy.

Filing Date

Source Excerpt

2020-08-31

Patrick D. Walsh is a nominee to the Board of Directors. He is founder of Diligence Team, LLC, a consulting practice serving clients in the healthcare industry. Mr. Walsh has served as Chairman of the Board of Directors of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP), a publicly traded specialty pharmaceutical company, since June 2018, and is a former member of its Audit and Compensation Committees. He has also served as a Director for Avid Bioservices, Inc. (NASDAQ:CDMO) since October 2017, and is Chairman of its Compensation Committee and a member of its Nominating Committee. Mr. Walsh currently serves as an Operating Partner at Ampersand Capital, a private-equity healthcare investment firm, and has served on the boards of directors of pharmaceutical companies as chairman, non-executive chairman and company director, as well as an executive advisor to private equity and venture capital firms. He also currently serves on the Board of Directors of Industria Chimica Emiliana, S.p.A. ("I.C.E."), a privately - held specialty API supplier to the pharmaceutical industry based in Milan, Italy.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-09